semaglutide triggered brand Millions using weight-loss drug copycats despite being riskier The Boom in New Weight

PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R and other metabolic genes that predict your individual semaglutide responsiveness

Tracking Progress Beyond the Scale: Metrics That Matter Weight loss is important, but scale numbers fluctuate due to water retention, muscle gain, and hormonal cycles

Yuying Luo, MD Medical Reviewer Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City

Before any treatment is started, Dr Botros performs a full medical history, physical exam, and comprehensive laboratory workup

Program information Medicare prescription coverage Individuals with Medicare Part D coverage may apply for next years PAP enrollment after October 15, 2026

Overall prescribing trends The study found that 1,970,374 patients were prescribed a GLP-1 RA between January 2018 and March 2025, with 9,376,686 total prescriptions during this period